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SUMMARY 
The effects of intracerebroventricular (ICV) administration ofthe mineralocorticoid receptor (MR) 
antagonist, RU28318, and the glucocorticoid receptor (GR) antagonist, RU38486, were studied on 
behavior of rats exposed to a compartment previously associated with a stressor, and placed 
subsequently in an elevated plus-maze test. Fear-motivated immobility behavior was attenuated 
by the MR antagonist ina dose of 50 or 100 ng ICV, whereas the GR antagonist alone or simultaneous 
administration fboth antagonists had no significant effect. In the elevated plus-maze, immediately 
after the exposure to the conditioned stressor, both the GR antagonist (50 ng) and MR antagonist 
(50 ng) increased the percentage of time the rats spent on open arms, and increased the amount 
of entries into these open arms. These data are interpretated in terms of the involvement of the 
GR and MR in fear and anxiety. 
Keywords--Mineralocorticoid; Glucocorticoid; Receptor: Immobility; Plus-maze: Anxiety. 
INTRODUCTION 
ADRENAL GLUCOCORTICOIDS APPEAR to have a dual and often opposing action on a 
variety of homeostatic processes including the behavioral expressions offear and anxiety 
(see review: Bohus, 1994; De Kloet, 1991). Removal of endogenous glucocorticoids by 
adrenalectomy (ADX) produces anxiogenic-like effects (File et al., 1979; Weiss et al., 
1970), whereas administration of corticosterone caused anxiolytic-like ffects (File et 
al., 1979). In contrast, it was reported that fear-motivated immobility was abolished by 
ADX and was restored after corticosterone r placement (Bohus, 1987). We propose that 
these different actions of corticosteroids are mediated by different corticosteroid receptor 
types located in diverse brain structures. 
Address correspondence and reprint requests to: Dr. S. Mechiel Korte, Department of Animal 
Physiology, University of Groningen, P.O. Box 14, 9750 AA Haren, The Netherlands: e-mail: 
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The existence of two intracellular receptor systems for corticosteroids has been 
demonstrated in the rat brain by radioligand binding, immunocytochemistry and in- 
situ hybridization (Chao et al., 1989; Fuxe et al., 1985; Herman et al., 1989; Reul 
& De Kloet, 1985; Van Eekelen et al., 1988). These receptors are designated as 
mineralocorticoid receptors (MRs; type I) and glucocorticoid receptors (GRs; type 
II). The two receptor types differ in their neuroanatomical distribution, their affinity 
for corticosterone, their regulation, and their function. The MRs are aldosterone 
selective in the periventricular brain and bind both corticosterone and aldosterone 
with high affinity in the limbic brain regions, for example, hippocampus, eptum, and 
amygdala (De Kloet et al., 1975; McEwen et al., 1968, 1986, 1992; Reul & De Kloet, 
1985). GRs bind corticosterone with a 10-fold lower affinity than the MRs. The GRs 
are widely distributed in the brain with highest concentration i regions involved in 
regulation of the stress response (Fuxe et al., 1985; Ratka et al., 1989; Reul & De 
Kloet, 1985; Sawchenko & Bohn, 1989; Van Eekelen et al., 1987). Low circulating 
levels of corticosterone predominantly occupy MRs, whereas after stress and during 
the circadian peak both receptor types are activated (Reul et al., 1987). MRs and 
GRs coordinately and differentially mediate the corticosteroid control of ion regulation 
and transmitter responsiveness (Bradbury et al., 1991; De Kloet & Reul, 1987; Evans 
& Arriza, 1989; Jo61s & De Kloet, 1992; Munck & N~iray-Fejes-T6th, 1992; Pearce 
& Yamamoto, 1993). 
The infusion of selective MR antagonists (RU28318), GR antagonists (RU38486), 
and selective agonists intracerebroventricularly (ICV) or locally in hippocampus allows 
to define receptor mediated effects in intact rats (De Kloet, 1991). Behavioral effects 
of the GR antagonist or the MR antagonist have been described in tests designed to 
examine learning and memory, and learned helplessness (De Kloet et al., 1988; 
Jeffereys et al., 1985, 1987; Oitzl et al., 1992a, 1992b, 1993; Papolos et al., 1993; 
Peeters et al., 1992). It was proposed that GRs are involved in consolidation processes, 
whereas MRs are needed for spatial and inhibitory avoidance learning. However, less 
attention was given to the constructs of fear and anxiety. Earlier, we observed that 
MR and GR antagonist reatment reduced the initial phase of the centrally CRF- 
induced heart rate stress response (Korte et al., 1993), suggesting stress reducing 
properties of both antagonists. 
The purpose of the present study was to investigate the role of central MRs and 
GRs in behavioral tests shown to have predictive validity as model of fear and anxiety 
by using these specific corticosteroid antagonists to selectively block the function of 
each corticosteroid receptor type. There is a growing body of evidence that different 
behavioral tests measure different aspects of fear and anxiety, and that these hypotheti- 
cal constructs may have different representations in the brain, both in terms of 
neuroanatomy and neurochemistry (Bohus et al., 1989; Korte et al., 1992b; LeDoux, 
1993; Silveira et al., 1993). The fear-motivated immobility test was used, in which 
animals show passive behavior, that is, immobility-freezing behavior to a situation 
previously associated with a uncontrollable stressor. This type of fear-motivated 
behavior is attenuated by classical and novel anxiolytics (Conti et al., 1990; Korte 
et al., 1990). Directly after the fear-motivated immobility test, rats were exposed to 
the elevated plus-maze test, in which they usually show a preference for the closed 
arms instead of open arms. The percentage of time spent on the open arms and the 
number of open arms entries are validated measures of anxiolytic-like ffects (Pellow 
et al., 1985). 
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METHODS 
Subjects 
For the fear-motivated immobility test and the elevated plus-maze, male Wistar rats 
(n = 96) (originally derived from Cpb, TNO, Zeist, The Netherlands and bred in our 
laboratory) weighing 300-340 g at the beginning of the experiments were used. They 
were housed individually in clear Plexiglas cages (25 x 25 x 30 cm) on a 12-h light-dark 
regime (lights on between 0700 and 1900h). All animals had free access to standard rat 
chow and tapwater. The experiments were carried out between 1000 and 1400h. 
Surgery 
The rats were secured in a stereotaxic frame for implantation ofunilateral intracerebro- 
ventricular (ICV) cannulae, under complete ther anaesthesia. The guide cannulae were 
positioned 1.0 mm above the right lateral ventricle with the tooth bar set at +5.0 mm at 
AP 0.6 mm and L --- 2.0 from bregma nd DV -3.2 mm from point of entry (Heinrichs 
et al., 1992; Pellegrino & Cushman, 1976). The rats were allowed at least 1 week for 
postsurgery ecovery. 
Treatment 
The steroid receptor antagonists were injected ICV at a dose range of 50-150 ng/2 tzl per 
rat 30-35 rain before the exposure of the animals to the test situation. The glucocorticoid 
antagonist (anti-GR; RU38486; 17/3-hydroxy-ll/3-(4-dimethylamino-phenyl)17c~-(l-pro- 
pynyl)estra-4,9-diene-3-one) (Gaillard et al., 1984; Moguilewski & Philibert, 1984) and 
the mineralocorticoid antagonist (anti-MR; RU28318; 3,3-oxo-7-propyl-17-hydroxy-an- 
drostan-4-en-17yl-propionic acid-lactone) (Perroteau et al., 1984) were provided by Rous- 
seI-UCLAF, Romainville, France. Both steroids were dissolved in ethanol; subsequently, 
a 0.9% NaCI solution was added to reach the appropriate concentration. The final concen- 
tration of ethanol was 2%. The vehicle control contained the same ethanol concentration. 
Each animal received only one ICV injection. The observations were made by trained 
observers who were blind to the treatment order. 
Statistics 
Comparisons between behavioral data of vehicle treated stressed and control animals 
were made by Student's t-tests. One-way analysis of variance (ANOVA) was performed 
on the data of vehicle- and drug-treated stressed animals. The Dunnett's posthoc t-test 
was used to compare the drug-treated stressed animals to the vehicle-treated stressed 
group. A probability level ofp -< .05 was taken as significant. 
FEAR-MOTIVATED IMMOBILITY 
Procedure 
The rats were trained in a dark compartment in which the electric foot shock would 
be applied (Korte et al., 1990). Briefly, the rats were placed in a waiting Plexiglas (25 x 
25 x 30 cm) cage next to the apparatus for 1 min, after which they were trained to enter 
from a platform to a dark compartment where they were allowed to stay for 5 rain. 
This procedure was repeated three times. During the final training trial an inescapable 
scrambled foot shock (0.6 mA, AC for 3 s) was given immediately upon entering the dark 
from the lit platform compartment. The rats were removed from the dark compartment 40
s after termination of the foot shock. On the next day, the animals were placed in the 
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waiting cage for 1 rain, whereafter they were directly transferred into the dark compart- 
ment but without any further foot shock. This procedure has been shown to induce 
immobility behavior accompanied by elevations in plasma corticosterone and plasma 
catecholamine levels in the rat (Korte al., 1992a). Each rat received an ICV injection of 
RU38486, RU28318, both antagonists ogether, or vehicle 30 min before reexposure to 
the former shock compartment. The effect of drug treatment on the duration of immobility 
(defined by the total lack of motion) was measured through amirror (tilted with an angle 
of 45 ° ) above the dark compartment during the second, third, and fourth minute of 
exposure to the dark former shock compartment (5-min period). 
ELEVATED PLUS-MAZE 
Procedure 
Directly after the 5-rain period exposure to the compartment in which they had pre- 
viously been shocked, rats were tested in the elevated plus-maze located in another 
soundproof room. The animals were already treated with vehicle, anti-MR (50, 150 ng) 
or anti-GR (50, 150 ng) or both anti-MR + anti-GR (50 ng+ 50 ng) 30 min before 
reexposure to the former shock compartment. The elevated plus-maze consisted of two 
open, 50 x 10 cm, and two enclosed arms, 50 × 10 x 40 cm, with an open roof, arranged 
such that the two arms of each type were opposite to each other (Pellow et al., 1985). 
Light intensity in the open arms and closed arms was 200-350 Ix and < 1 lx, respectively. 
The maze was elevated to a height of 100 cm. Animals were placed in the center of the 
maze facing an enclosed arm at the start of the experiment. Each rat was tested for 5 
min on the elevated plus-maze. The maze was carefully wiped with a damp cloth after 
each animal. The number of entries into closed arms, and into open arms and the time 
spent in the open arms and in the closed arms in the elevated plus-maze were measured. 
Time spent on open arms relative to open + closed arms is used as an index for the 
anxiolytic or anxiogenic effects (Pellow et al., 1985; Wahlestedt et al., 1993). 
RESULTS 
Behavioral Effects of R U38486 and R U28318 on Fear-Motivated Immobility 
Figure 1 shows that during reexposure to the former shock compartment duration of 
immobility was increased in stressed animals vs. nonshocked controls after vehicle 
treatment (p = .0013). ANOVA of data of stressed animals revealed a significant drug 
treatment effect, F(7, 80) = 3.85; p = .0012. This was because two doses of the anti- 
MR RU28318 (50 and 100 ng, ICV) reduced the fear-motivated immobility in stressed 
rats compared to vehicle treated stressed rats (p -- .05). The anti-GR RU38486 failed 
to show significant effects at these doses. No significant effects were found with the 
highest dose (150 ng) of either antagonist or with simultaneous treatment of MR and GR 
antagonists (both 50 ng). 
Behavioral Effects of RU38486 and RU28318 in the Elevated Plus-Maze Test 
Figure 2 shows that exposure to the former shock compartment prior to the plus- 
maze test decreased the percentage oftime on the open arms in stressed vs. nonshocked 
vehicle treated animals (p = .0283). Analysis of variance revealed a significant drug 
treatment effect, F(5, 47) = 6.616; p < .0001. Furthermore, both RU28318 (50 ng) and 
RU38486 (50 ng) increased the percentage of time spent on the open platform (both p < 
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FIG. I: Time spent on immobil i ty behavior  of rats during exposure to the former shock compartment ,  
30 min after ICV-administered vehicle (controls,  n = 8; stressed, n = 19), ant imineralocort icoid 
(RU28318; 50 ng, n = 8; 100 ng, n = 13; 150 ng, n = 7), antiglucocort icoid (RU38486; 50 ng, n = 
8; 100 ng, n = 15; 150 ng, n = 7) or RU28318 + RU38486 (both 50 ng, n = l l ) .  *p -< .05: **p -< 
.01, significantly different from control.  
.01) in stressed animals. Neither the higher doses of RU28318 and RU38486 nor the 
combination of the drugs altered the behavior in the plus-maze. 
Figure 3 shows that neither prior exposure to a situation previously associated with 
a stressor nor drug treatment produced a significant effect in the number of closed arm 
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F[o. 2: Percent of t ime spent in the open arms relative to cummulat ive t ime on all four arms in 
the elevated plus-maze directly after the rats'  exposure to the condit ioned emotional  stressor.  
Directly after the 5-min period exposure to the former shock compartment ,  animals treated with 
vehicle (controls,  n = 8 stressed, n = 12), ant imineralocort icoid (RU28318; 50 ng, n = 8; 150 ng, 
n = 7), ant iglucocort icoid (RU38486; 50 ng, n = 8; 150 ng, n = 7), or RU28318 + RU38486 (both 
50 ng, n = 11) were placed in the elevated plus-maze. **p -~ .01, significantly different from 
control.  
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FIG. 3: Closed arm entries (mean -+ SEM) in rats given a 5-min test in the elevated plus-maze, 
directly after the rats' exposure to the emotional stressor. For further explanations ee Fig. 2. 
Figure 4 shows that prior exposure to a situation previously associated with a stressor 
significantly decreased the number of open arm entries in the plus-maze test (p = .001). 
However,  drug treatment in the stressed animals showed a significant effect, F(5, 47) = 
7.811;p < .0001, due to an increase in the number of open entries in the RU28318 (50 
ng) (p < .01) and RU38486 (50 ng) (p < .01) treated animals. 
DISCUSSION 
The present study shows that if rats are reexposed to a compartment previously 
associated with a stressor, the MR is implicated in the control of fear-motivated immobil- 
ity exerted by corticosterone. The MR antagonist, RU28318 (50 and 100 ng, ICV), 
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FIG. 4: Open arm entries (mean - SEM) in rats given a 5-min test in the elevated plus-maze, 
directly after the rats' exposure to the emotional stressor. For further explanations ee Fig. 2. 
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not significantly affect the fear-motivated immobility. Fear-motivated immobility is also 
abolished following ADX and reinstated following corticosterone substitution. The syn- 
thetic glucocorticoid examethasone that activates GR, does not restore the immobility 
response (Bohus, 1987). Threat-induced freezing in pups may be of the same nature as 
the immobility response in adult rats. It is supposed that threat-induced behavioral 
inhibition reduces the risk of attack from predators. Recently, Takahashi and Rubin 
(1993) have demonstrated that removal of adrenal hormones effectively reduced the 
occurrence of threat-induced freezing in pups. Daily injections of corticosterone were 
effective in restoring the developmental ppearence of freezing in ADX pups. Collec- 
tively, the data suggest that MRs may be involved in behavioral passivity during stressful 
conditions in which the animal has no active control. In contrast, consolidation of acquired 
immobility in the Porsolt-swimming test was disrupted after posttrial (poststress) adminis- 
tration of the GR antagonist, whereas the MR antagonist was not effective (De Kloet et 
al., 1988). However, this immobility response isprobably not similar to the threat-induced 
immobility. Indeed, there exists evidence to indicate that rats have learned to inhibit 
rapid swimming movements as an energy-conserving strategy (Hawkins et al., 1978). 
In the elevated plus-maze, the "anxious" behavior was enhanced by prior exposure 
to a conditioned stressor, that is, reexposure to a compartment previously associated 
with an inescapable uncontrollable stressor. The behavior in the plus-maze seems more 
easily to be altered by the emotional consequences of the stressor (present study; Hein- 
richs et al., 1992) than the stressor itself (Falter et al., 1992; Steenbergen et al., 1991). 
Furthermore, our recent findings suggest hat absence of controllability of the stres- 
sor - i .e . ,  inescapable foot shock--leads to the enhancement of "anxious" behavior 
(Bohus et al., in preparation). Accordingly, prior exposure to an emotional stressor 
as induced by uncontrollable aversive stimuli enhances the anxiety state (generalized 
anxiety?) as indicated by the reduced exploration of the open arms of the plus-maze as 
compared to nonstressed controls. Both the MR antagonist (RU28318) and the GR 
antagonist (RU38486) treatment led to an increase in time spent on these open arms and 
an increase of number of entries into the open arms. Such a preference for the open 
arms may be interpreted as an anxiolytic-like ffect. The effect of the MR antagonist on 
the rat's performance in the plus-maze is not neccessarily a direct one but may be a 
consequence of its action in the former test situation. Interestingly, the MR and GR 
antagonists showed no effects on plus-maze behavior in case fear was not potentiated 
by prior exposure to an emotional stressor (Oitzl & De Kloet, unpublished results). 
Therefore, it is concluded that the MR and GR antagonists do not have a general anxiolytic 
action, but may have anxiolytic-like actions when the state of anxiety is enhanced by 
prior stressor exposure. Accordingly, it has been reported that corticosteroids may play 
an important role in the processing of relevant stimuli (Fehm-Wolfsdorf et al., 1993). 
The ability to integrate incoming stimuli was decreased in patients lacking cortisol and 
was normalized by glucocorticoid replacement (Henkin, 1970). Such mechanisms may 
be involved in the present results. 
In summary, the MR is implicated in the corticosterone control of behavioral passivity 
in stressful situations in which the animal has no active control. It is probably that 
steroid-serotonin interactions in the raphe-hippocampal system underly these MR-medi- 
ated behavioral effects (Biegon et al., 1985; Chalmers et al., 1993; De Kloet et al., 1986; 
JoEls & De Kloet, 1992; JoEls et al., 1991; Meijer & De Kloet, 1994; Mendelson & 
McEwen, 1990). The mechanism(s) by which GR-mediated effect on anxiety is organized 
is not known yet. The relation to the GABAffbenzodiazepine receptor complex (Majewski 
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et al., 1985; Sutanto & De Kloet, 1993) may deserve attention. Accordingly, the GR 
antagonist may reduce the enhanced state of anxiety, probably via a different mechanism. 
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